DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 170 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $232,343 | -0.4% | 18,266 | +10.3% | 0.00% | – |
| Q2 2023 | $233,263 | -3.1% | 16,567 | +6.3% | 0.00% | – |
| Q1 2023 | $240,773 | +4.6% | 15,584 | +11.0% | 0.00% | – |
| Q4 2022 | $230,181 | +4.2% | 14,044 | +17.3% | 0.00% | – |
| Q3 2022 | $221,000 | +64.9% | 11,968 | +16.8% | 0.00% | – |
| Q2 2022 | $134,000 | -79.3% | 10,250 | -46.2% | 0.00% | – |
| Q3 2021 | $648,000 | -8.5% | 19,056 | -1.5% | 0.00% | – |
| Q2 2021 | $708,000 | -24.4% | 19,353 | -7.3% | 0.00% | -100.0% |
| Q1 2021 | $937,000 | -22.9% | 20,877 | -2.1% | 0.00% | 0.0% |
| Q4 2020 | $1,216,000 | +43.7% | 21,315 | +29.2% | 0.00% | 0.0% |
| Q3 2020 | $846,000 | -17.8% | 16,495 | -4.3% | 0.00% | 0.0% |
| Q2 2020 | $1,029,000 | +229.8% | 17,235 | +127.7% | 0.00% | – |
| Q1 2020 | $312,000 | -29.9% | 7,568 | +5.7% | 0.00% | – |
| Q4 2019 | $445,000 | – | 7,157 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $15,385,743 | 19.76% |
| Redmile Group, LLC | 4,475,384 | $56,926,884 | 2.71% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,897,606 | $87,737,548 | 1.93% |
| Parkman Healthcare Partners LLC | 597,403 | $7,598,966 | 1.39% |
| Ghost Tree Capital, LLC | 325,000 | $4,134,000 | 1.36% |
| BRAIDWELL LP | 3,336,221 | $42,436,731 | 1.34% |
| AlphaCentric Advisors LLC | 132,000 | $1,679,040 | 0.95% |
| ARMISTICE CAPITAL, LLC | 4,612,000 | $58,664,640 | 0.90% |
| Sunesis Advisors, LLC | 96,299 | $1,224,923 | 0.87% |
| EcoR1 Capital, LLC | 993,000 | $12,630,960 | 0.43% |